Legal Representation
Attorney
Lori K. Hall
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 12, 2017 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Sep 12, 2017 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Feb 10, 2017 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Feb 10, 2017 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Feb 10, 2017 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jan 25, 2017 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jul 22, 2016 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 22, 2016 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 22, 2016 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 14, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 14, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 13, 2016 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 29, 2016 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Jan 29, 2016 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jan 29, 2016 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jul 22, 2015 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 22, 2015 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 22, 2015 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 16, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 16, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 14, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 7, 2015 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 8, 2015 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Jan 8, 2015 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jan 8, 2015 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Dec 23, 2014 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 20, 2014 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2014 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jun 20, 2014 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 2, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 23, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 9, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 14, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 13, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 6, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of all neurological diseases, neurosurgical conditions, neuropsychological diseases and disorders, and neuro-degenerative disorders and diseases; pharmaceutical preparations comprising, proteins, protein kinase or phosphatas; nutraceuticals, vitamins, minerals, nutritional and dietary supplements for the treatment of all neurological diseases, neurosurgical conditions and neuro-degenerative disorders and diseases; Medical and scientific research services; scientific testing services, namely, medical testing services; laboratory medical research services; Research relating to medicine, neuroscience, neuropsychology or clinical psychology; Pharmaceutical research and development services; medical services, namely, medical research, medical testing and medical laboratory services; consultancy services relating to medical research and testing, pharmacy and similar fields, namely, medical research and testing; clinical tests on healthy or unhealthy human beings or animals to study the effects of a medicine or a treatment method
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical and scientific research in the field of neurological diseases, neurosurgical conditions, neuropsychological diseases and disorders, and neuro-degenerative disorders and diseases; Medical research; Pharmaceutical research and development
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042